Skip to main content

Table 1 Baseline characteristics

From: Metabolic risk factors for esophageal squamous cell carcinoma and adenocarcinoma: a prospective study of 580 000 subjects within the Me-Can project

  

Cases

Total cohort1

  

Adenocarcinoma

Squamous cell carcinoma

Other or undifferentiated morphology

All cases

 

Subjects, n

 

114

184

26

324

577259

Sex

Male

102 (89.5)

144 (78.3)

22 (84.6)

268 (82.7)

288930 (50.1)

Female

12 (10.5)

40 (21.7)

4 (15.4)

56 (17.3)

288329 (49.9)

Age at baseline, mean (SD)

49.6 (10.1)

51.0 (10.9)

51.2 (10.1)

50.5 (10.5)

44.0 (11.7)

Cohort, n (%)

Oslo

13 (11.4)

37 ((20.1)

5 (19.2)

55 (17.0)

16714 (2.9)

NCS

31 (27.2)

29 (15.8)

4 (15.4)

64 (19.8)

50922 (8.8)

CONOR

10 (8.8)

14 (7.6)

3 (11.5)

27 (8.3)

109403 (19.0)

40-y

5 (4.4)

6 (3.3)

1 (3.8)

12 (3.7)

128742 (22.3)

VHM&PP

16 (14.0)

40 (21.7)

5 (19.2)

61 (18.8)

159444 (27.6)

VIP

16 (14.0)

8 (4.3)

1 (3.8)

25 (7.7)

79360 (13.7)

MPP

23 (20.2)

50 (27.2)

7 (26.9)

80 (24.7)

32674 (5.7)

Fasting time, n (%)

< 4 hrs

43 (37.7)

64 (34.8)

8 (30.8)

115 (35.5)

242246 (42.0)

4-8 hrs

14 (12.3)

14 (7.6)

5 (19.2)

33 (10.2)

57409 (9.9)

> 8 hrs

57 (50.0)

106 (57.6)

13 (50.0)

176 (54.3)

277604 (48.1)

BMI, mean (SD)

 

27.1 (3.8)

24.0 (3.3)

26.0 (4.2)

25.3 (3.8)

25.3 (4.0)

Mid BP2 mmHg, mean (SD)

110.6 (12.9)

112.4 (15.3)

111.9 (12.7)

111.7 (14.3)

104.4 (13.7)

Glucose mmol/l, median (IQR)

5.4 (4.8-5.4)

5.3 (4.7-5.3)

5.1 (4.6-5.6)

5.3 (4.7-5.9)

5.1 (4.6-5.6)

Cholesterol mmol/l, mean (SD)

6.1 (1.1)

6.2 (1.1)

6.4 (1.3)

6.2 (1.1)

5.7 (1.2)

Triglycerides mmol/l, median (IQR)

1.63 (1.11-2.43)

1.44 (1.02-2.11)

1.82 (1.12-2.80)

1.57 (1.05-2.33)

1.29 (0.91-1.91)

Smoking status, n (%)

Never

25 (21.9)

29 (15.8)

4 (15.4)

58 (17.9)

257721 (44.6)

Former

36 (31.6)

25 (13.6)

5 (19.2)

66 (20.4)

158358 (27.4)

Current

52 (45.6)

129 (70.1)

17 (65.4)

198 (61.1)

159624 (27.7)

 

Missing

1 (0.9)

1 (0.5)

0

2 (0.6)

1556 (0.3)

  1. 1After exclusion of 1441 subjects with a follow-up less than 1 year.
  2. 2Mid blood pressure = [(systolic blood pressure + diastolic blood pressure)/2] mm Hg).
  3. Abbreviations: Oslo The Oslo study I cohort, NCS The Norwegian County Study, CONOR The cohort of Norway, 40-y: The Age 40-programme, VHM&PP The Vorarlberg Health Monitoring and Prevention Program, VIP The Västerbotten Intervention Project, MPP The Malmö Preventive Project, BMI body mass index (kg/m2).